Raia Drogasil (RADLY) and Its Rivals Head-To-Head Analysis

Raia Drogasil (OTCMKTS:RADLY) is one of 150 public companies in the “Consumer Staples Distribution & Retail” industry, but how does it weigh in compared to its rivals? We will compare Raia Drogasil to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, profitability, valuation, earnings and dividends.

Dividends

Raia Drogasil pays an annual dividend of $0.02 per share and has a dividend yield of 0.5%. Raia Drogasil pays out 13.3% of its earnings in the form of a dividend. As a group, “Consumer Staples Distribution & Retail” companies pay a dividend yield of 3.8% and pay out 36.7% of their earnings in the form of a dividend.

Institutional and Insider Ownership

45.0% of shares of all “Consumer Staples Distribution & Retail” companies are held by institutional investors. 19.7% of shares of all “Consumer Staples Distribution & Retail” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Raia Drogasil and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Raia Drogasil	$7.92 billion	$232.27 million	25.33
Raia Drogasil Competitors	$34.28 billion	$835.88 million	15.84

Raia Drogasil’s rivals have higher revenue and earnings than Raia Drogasil. Raia Drogasil is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Raia Drogasil and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Raia Drogasil	0	1	0	0	2.00
Raia Drogasil Competitors	2237	8232	10003	453	2.41

As a group, “Consumer Staples Distribution & Retail” companies have a potential upside of 59.90%. Given Raia Drogasil’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Raia Drogasil has less favorable growth aspects than its rivals.

Profitability

This table compares Raia Drogasil and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Raia Drogasil	2.99%	20.12%	5.88%
Raia Drogasil Competitors	-25.67%	1.91%	2.62%

Summary

Raia Drogasil rivals beat Raia Drogasil on 9 of the 14 factors compared.

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.